LogicBio Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
LogicBio Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2022.
  • LogicBio Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 33M shares, a 0.05% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 33M +17.1K +0.05% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 33M +740K +2.3% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 33M +905K +2.82% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 33M +1.18M +3.7% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 32.9M +9.26M +39.1% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 32.2M +8.72M +37.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 32.1M +8.84M +38.1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 31.8M +8.74M +37.9% Dec 31, 2020 10-K 2022-03-04
Q3 2020 23.7M +919K +4.04% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 23.5M +982K +4.36% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 23.2M +868K +3.88% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 23M +849K +3.82% Dec 31, 2019 10-K 2021-03-15
Q3 2019 22.8M +20.6M +946% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 22.5M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 22.3M Mar 31, 2019 10-Q 2019-05-14
Q4 2018 22.2M +20.6M +1281% Dec 31, 2018 10-K 2020-03-16
Q3 2018 2.18M Sep 30, 2018 10-Q 2018-12-03
Q4 2017 1.61M Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.